Connective Tissue Matrix for Rotator Cuff Tendinopathy

Description

The purpose of this research study is to determine if the effectiveness of a single injection of CTM Boost in the treatment of patients with rotator cuff tendinopathy (RCT) is as effective as a single injection of platelet rich plasma (PRP) in reducing the symptoms of RCT.

Conditions

Tendinopathy, Shoulder Pain, Rotator Cuff Tendinitis, Rotator Cuff Tendinosis

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this research study is to determine if the effectiveness of a single injection of CTM Boost in the treatment of patients with rotator cuff tendinopathy (RCT) is as effective as a single injection of platelet rich plasma (PRP) in reducing the symptoms of RCT.

Connective Tissue Matrix (CTM) for Rotator Cuff Tendinopathy: A Randomized Controlled Trial

Connective Tissue Matrix for Rotator Cuff Tendinopathy

Condition
Tendinopathy
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

Allegheny Health Network Allegheny General Hospital, Pittsburgh, Pennsylvania, United States, 15212

Pittsburgh

Allegheny Health Network Federal North Medical Office Building, Pittsburgh, Pennsylvania, United States, 15212

Wexford

AHN Wexford Health & Wellness Pavilion, Wexford, Pennsylvania, United States, 15090

Wexford

AHN Wexford Hospital, Wexford, Pennsylvania, United States, 15090

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients aged 18-80 years old with rotator cuff tendinopathy
  • * A PRP or CTM-type injection was determined by the clinician to be the proper medical treatment course and patient is willing to undergo the injection
  • * Patients with adhesive capsulitis
  • * Patients with acromio-clavicular joint impingement, retracted tears, significant labral lesions or significant glenohumeral arthrosis
  • * Patients with joint instability
  • * History of shoulder surgery or corticosteroid injection in the past 3 months
  • * Patients with any medical conditions that affect healing, such as end-stage renal disease or uncontrolled diabetes

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute),

Patrick Demeo, MD, PRINCIPAL_INVESTIGATOR, Allegheny Health Network

Study Record Dates

2028-01-15